IBOV 169,816.64 ▲ 0.31% IPC MEX 71,365.93 ▲ 0.23% MERVAL 2,848,945 — — USD/BRL5.78▼ 0.10% USD/MXN18.44▼ 0.45% USD/CLP992.33▼ 0.72% USD/COP3,304▼ 0.42% USD/PEN3.41▲ 0.05% USD/ARS1,552▲ 0.14% USD/UYU40.61▲ 3.40% USD/PYG6,212▲ 3.22% USD/BOB11.64▲ 2.89% USD/DOP60.27▲ 1.93% USD/CRC441.73▲ 1.57% USD/GTQ7.64▲ 3.17% USD/HNL26.89▲ 2.99% USD/NIO36.62▲ 2.50% USD/VES913.46▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.69▲ 2.79% USD/TTD6.70▲ 1.69% EUR/BRL6.35▲ 1.76% BRENT 93.12 ▲ 0.74% WTI 85.56 ▼ 0.19% IRON ORE 161.91 — — COPPER 5.99 ▼ 0.06% GOLD 3,817 ▼ 0.92% SILVER 46.72 ▼ 0.15% SOY 1,227 ▼ 0.18% CORN 446.50 ▼ 0.50% WHEAT 607.50 ▲ 3.49% COFFEE 279.95 ▼ 0.27% SUGAR 18.17 ▲ 0.39% ORANGE JUICE 133.75 ▼ 1.76% COTTON 81.30 ▲ 5.58% COCOA 5,184 ▲ 2.82% BEEF 222.80 ▲ 1.12% CATTLE 327.90 ▼ 2.81% LITHIUM 56.42 ▼ 3.98% PETR4 43.98 ▼ 0.09% VALE3 60.34 ▼ 0.59% ITUB4 40.89 ▼ 0.99% BBDC4 14.41 ▲ 1.26% ABEV3 15.93 ▲ 0.38% BBAS3 14.62 ▼ 2.21% B3SA3 14.65 ▼ 1.08% WEGE3 51.15 ▲ 1.49% PRIO3 63.96 ▲ 2.12% SUZB3 55.39 ▼ 0.20% RENT3 29.66 ▲ 1.19% AZZA3 15.64 ▼ 3.10% CSAN3 3.25 ▲ 5.18% RAIZ4 19.11 ▼ 4.45% PCAR3 2.89 ▲ 11.15% GMAT3 4.18 ▲ 1.21% PSSA3 45.92 ▲ 0.83% CVCB3 0.78 ▼ 1.27% POSI3 3.13 ▲ 0.97% SLCE3 18.06 ▲ 1.18% NATU3 4.75 ▼ 3.06% BRKM5 2.75 ▼ 3.17% RANI3 8.22 ▲ 0.37% CSNA3 3.77 ▲ 2.45% IBOV 169,816.64 ▲ 0.31% IPC MEX 71,365.93 ▲ 0.23% MERVAL 2,848,945 — — USD/BRL 5.78 ▼ 0.10% USD/MXN 18.43 ▼ 0.50% USD/CLP 992.33 ▼ 0.72% USD/COP 3,304 ▼ 0.42% USD/PEN 3.41 ▲ 0.05% USD/ARS 1,552 ▲ 0.14% USD/UYU 40.61 ▲ 3.40% USD/PYG 6,212 ▲ 3.22% USD/BOB 11.64 ▲ 2.89% USD/DOP 60.27 ▲ 1.93% USD/CRC 441.73 ▲ 1.57% USD/GTQ 7.64 ▲ 3.17% USD/HNL 26.89 ▲ 2.99% USD/NIO 36.62 ▲ 2.50% USD/VES 913.46 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.69 ▲ 2.76% USD/TTD 6.70 ▲ 1.98% EUR/BRL 6.35 ▲ 1.76% BRENT 93.12 ▲ 0.74% WTI 85.56 ▼ 0.19% IRON ORE 161.91 — — COPPER 5.99 ▼ 0.06% GOLD 3,817 ▼ 0.92% SILVER 46.72 ▼ 0.15% SOY 1,227 ▼ 0.18% CORN 446.50 ▼ 0.50% WHEAT 607.50 ▲ 3.49% COFFEE 279.95 ▼ 0.27% SUGAR 18.17 ▲ 0.39% ORANGE JUICE 133.75 ▼ 1.76% COTTON 81.30 ▲ 5.58% COCOA 5,184 ▲ 2.82% BEEF 222.80 ▲ 1.12% CATTLE 327.90 ▼ 2.81% LITHIUM 56.42 ▼ 3.98% PETR4 43.98 ▼ 0.09% VALE3 60.34 ▼ 0.59% ITUB4 40.89 ▼ 0.99% BBDC4 14.41 ▲ 1.26% ABEV3 15.93 ▲ 0.38% BBAS3 14.62 ▼ 2.21% B3SA3 14.65 ▼ 1.08% WEGE3 51.15 ▲ 1.49% PRIO3 63.96 ▲ 2.12% SUZB3 55.39 ▼ 0.20% RENT3 29.66 ▲ 1.19% AZZA3 15.64 ▼ 3.10% CSAN3 3.25 ▲ 5.18% RAIZ4 19.11 ▼ 4.45% PCAR3 2.89 ▲ 11.15% GMAT3 4.18 ▲ 1.21% PSSA3 45.92 ▲ 0.83% CVCB3 0.78 ▼ 1.27% POSI3 3.13 ▲ 0.97% SLCE3 18.06 ▲ 1.18% NATU3 4.75 ▼ 3.06% BRKM5 2.75 ▼ 3.17% RANI3 8.22 ▲ 0.37% CSNA3 3.77 ▲ 2.45%
since 2009
Wednesday, November 18, 2026

Covid-19 Brazil

Governor Doria Says Covid-19 Vaccine, If Approved, Will Be Compulsory in São Paulo

By · · 3 min read

RIO DE JANEIRO, BRAZIL – São Paulo Governor João Doria said on Friday, October 16th, that the Covid-19 vaccine will be mandatory throughout the state if approved by the National Health Regulatory Agency (ANVISA). Doria had been repeating in recent weeks that he thought it was appropriate to make it obligatory, but had not yet announced the measure. According to the governor, only individuals with a medical certificate will be exempt from immunization.

São Paulo Governor João Doria said yesterday that the Covid-19 vaccine will be mandatory throughout the state if approved by the National Health Surveillance Agency Anvisa.
São Paulo Governor João Doria said yesterday that the Covid-19 vaccine will be mandatory throughout the state if approved by ANVISA.
RT
Ask Rio Times
This story and the bigger picture.
Open the full Ask Rio Times →

Doria also attacked President Jair Bolsonaro once again, accusing him of “politicizing” the vaccine. The attacks come in the face of the threatened agreement between the São Paulo government and the Ministry of Health to allow CoronaVac, the vaccine developed and tested by the Butantan Institute in partnership with the Chinese laboratory Sinovac, to be distributed in other states by the SUS (National Health System). According to Doria, this will be decided in a meeting next Wednesday, October 21st.

The São Paulo government’s idea is to have the CoronaVac approved by ANVISA in time to begin the vaccination of healthcare professionals as early as December in the state. The trials should be finalized this weekend and the results will be delivered to the agency on Monday.

“It will be mandatory in São Paulo, except for those with medical guidance and attestation that they can not take it. And we will adopt legal measures if there is any opposition in this respect,” said Doria during a press conference at the Bandeirantes Palace in São Paulo.

The governor is still hopeful that the Butantan vaccine will be distributed nationally. To this end, Doria will attend a decisive meeting next week in Brasília with Minister of Health Eduardo Pazuello. The governor also promises to meet with the ANVISA director Antônio Barra on the same day.

The LatAm Brief

One email, every weekday morning. What moved in Latin American markets, politics and expat life.

Yesterday’s subject line: “US rule would require licences for AI chips to Brazil”

“São Paulo intends to share the Butantan vaccine so that other states may vaccinate their population. São Paulo will. I have already guaranteed that the 45 million Brazilians in São Paulo will be vaccinated”, said Doria, recalling the 46 million CoronaVac doses pledged by December.

Should an agreement with the federal government fail, the São Paulo government has already stated that it will discuss directly with other states to supply them with the Butantan vaccine.

Positive expectation

A summary of the CoronaVac trial reports in Brazil will be forwarded to ANVISA on Monday, October 19th, but Doria said that the agency now has all the required data, since these are monitored daily.

“So far, with no side effects – i.e. the positive trials of the CoronaVac, the Butantan vaccine with the Sinovac laboratory,” said the governor.

The trials in Brazil are in their final stage of the phase 3 clinical studies. According to the executive coordinator of the Covid-19 Contingency Center in São Paulo, João Gabbardo, the first two trial phases proved the vaccine to be 98 percent effective, while the Ministry of Health speaks of a figure over 50 percent needed to obtain ANVISA approval.

Gabbardo said he believes that the CoronaVac meets all the requirements listed by the Ministry of Health to be incorporated into the PNI (National Immunization Program).

Source: UOL

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error

Living in or visiting São Paulo? See this month's events and our São Paulo city guide with rents, safety and upcoming concerts.

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.